Perpetua Resources offers a unique value proposition as a low-cost gold producer with a critical antimony byproduct. See why ...

The current digital revolution, despite its immense potential, has been engineered in favor of capitalist profit and control.

Q4 2025 Earnings Call Transcript November 7, 2025 Franklin Resources, Inc. beats earnings expectations. Reported EPS is $0.67 ...

Canadian Natural Resources Limited ( CNQ:CA) Discusses Strategic Advantages, Asset Base, and Outlook at Investor Open House November 7, 2025 8:30 AM EST ...

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...

Operator: Good afternoon, ladies and gentlemen, and welcome to the Quest Resource Holding Corporation’s Third Quarter 2025 Earnings Conference Call. At this time, all lines are […] ...

Pipeline programs continue to advance, with four clinical data readouts anticipated in 2026; APG777 trial readout timelines accelerated, with Phase 1b in asthma and APEX 52-week Part A data in AD ...

Detailed price information for Solaris Resources Inc (SLS-T) from The Globe and Mail including charting and trades.

Announced new clinical trial agreement with Pfizer to evaluate palazestrant in combination withatirmociclib in ER+/HER2- metastatic breast cancerInitiated OPERA-02 Phase 3 trial of palazestrant in ...

Detailed price information for Casi Pharmaceuticals Inc (CASI-Q) from The Globe and Mail including charting and trades.

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and ...